Timed Health Corporation's original offering opened on March 4, 2021 and was completed on May 1, 2021. Except for the Updates section which may contain more recent information, the information on this page was accurate as of May 1, 2021.

Timed Health Corporation

What beats next day shipping, all night ERs and pharmacies? “Already having what you newly-needed in enough quantity to conveniently get the rest later.” Highly patented, scalable, sustainable early priority date mass market telehealth, telemedications, forecasting and prescribing software platforms


Our Founders extensively patented in 2011 much of what is today modern telehealth. Our fully patented THAT, Timed Health Assistive Technology Platform is based on predictive data science which can form the basis for future artificial intelligence, which together enables the earliest form of healthcare therapeutics feasible which can help reduce the need for rationing costlier healthcare later.

Our goal is to help physicians forecast and enable providing medications that are 40% to 80% likely to be needed from one day to 4 months before actual need. When fully applied over time 30% of health and economic losses can be erased. Timed Health enhances patient empowerment, engagement and to improve health and economic outcomes beginning with low risk changes in asthma, diabetes, hypertension, infections, and sexual function in the first year. Thereafter growing into other acute and chronic health conditions, including cancer, dementia, heart, renal, and liver failure.

Deal Highlights

  • 5 US patents issued and with more soon to be filed including two in the European, Canadian and India Patent Offices.
  • Raised over $4M in previous funding now converted to common stock.
  • Initial joint venture discussions have been held with Aon, Cerner, Cigna, Costco, Kaiser and Stanford University.
  • Experienced team and Board of Directors with experience on both private and public company Boards.


HEALTHCARE DELAYS costly in time, money, stress and worsening health.


Highly patented Timed Health beats ignoring a NEW change in your health, or delaying your NEW healthcare. Or waking your doctor, or going to all night ERs and pharmacies for a minor change in your health before it worsens.Like a new infection, a new rising blood pressure or new rising blood glucose levels,

Highly patented, scalable, sustainable early priority date mass market telehealth, telemedications, forecasting and prescribing software platforms. Immediate patient implementation of forecasted stored timed new medications. Apps, online, on premises EMR and Employee Benefits to multiply user bandwidth, efficiency and ROI.


Diabetes and hypertension are only two of the many prevalent diseases that are too often ignored or treated too late. Mass demands are constantly increasing for more people to get better healthcare more often, efficiently, and affordably.

  • These problems are often compounded by:
  • Physician and consumer manpower shortages
  • Low physician incomes and outcomes
  • Healthcare inefficiency and insufficiency
  • Costlier delayed healthcare
  • Common cumulative disease progressive high-cost complicated outcomes
“The Centers for Disease Control and Prevention (CDC) recently reported that more than 30 million Americans now have diabetes, and more than 7 million of them haven’t received a proper diagnosis.”

Timed Health’s (TH) platform is designed to help physicians time, forecast and provide determined prefilled new medications and healthcare supported by patented predictive data science. These options enable patients to have medications and healthcare in advance of their potential new medical, trial or gap-bridging medication needs.

Based on patented Predictive Data Science, TH is a comprehensive outpatient telehealthcare and telemedication software solution that is perfectly suited to assist doctors and patients with low-risk health issues to have easy, often immediate access to the medications they need quickly. Timed Health's solution is ideally e-prescribe and initiated prior to discharge from an online, office or clinic visit, ED or hospital to help avoid safely avoidable expensive admissions and readmissions - saving both the patient and the healthcare system health, time and money.

Predictive analytics

Business Model

Recurring Revenue Model

Our products are software in the form of predictive data science, prescribing and electronic medical records software. Our business model makes money through technology sales to client hospitals, integrated delivery networks, employers, governments, insurers, physicians, patients, electronic medical records,and direct to consumers revenue streams.

Employers and Insurers

A pre-tax health benefit model is to become qualified within Series A.


Patented Software Assistive Electronic Medical Records.

“92% of 120 randomly selected healthcare provider prescribers supported using Timed Health for a growing list of their patients and conditions healthcare.”



Diabetes and Hypertension have a Total Addressable Market (TAM) of over $180 Bn in the US, afflicting approximately 50 million people, with a Serviceable Addressable Market (SAM) of 6 to 10 million people spending $15 to $30 Bn on ambulatory healthcare and medications.

US medication market sales in 2018 for antidiabetics was $78.7 billion, antibiotics and vaccines $40.6 billion, antihypertensive medications were $29.9 billion. Humira as an immunotherapy single drug example, alone in 2019 had $21.9 billion revenue, the largest for a single drug.


Timed Health does not employ physicians or retain as consultants physicians who are using Timed Health in their practice .

Standard Health Insurances and Health Savings Accounts (HSA) covers most healthcare and many telehealthcare physician fees. Physician practices wishing to move in the direct-pay direction price-tiered in part or in whole which can generate supplemental physician revenue.

Timed Health Early Bird Practices are those choosing to transform in-part to increasingly apply Timed Health Technology to more and more patients.

Or physicians may elect to transform their practices to high-end premium Timed Health Signature Practices which transforms their practice into being 100% focused on fully applied Timed Health technologies. Timed Health Signature Physician Practices reduce their census to care for fewer patients paying greater fees for greater access to their physicians. Patient Memberships supplement insurance reimbursement for physicians.


Timed Health Signature Physician Practices may charge patients $1,200 to $1,800 annually which passes through to Timed Health $300 to $450 per patient annually. Our Early Bird Practices charges are tiered in tenth percentiles, ranging from 10% to 50% of the Signature Level charges ranging from $0 to $900 annually for assistive technology fees for expedited services after-hours.

Direct to Consumer Patients and Physicians

Direct to consumer Timed Health Memberships begin at $0.25 per member per month.

Timed Health’s direct to consumer co-pay fees are based on physician time expenditure, urgency, complexity and connectivity to pre-authorize or authorize implementation of pre-filled new medications.

Fees may be charged to payers on a Direct-Pay, Health Savings Account, or certain pre-qualified Employer or Third-Party Payer co-pay basis. User fees are based on frequency and intensity of use, greater use lowers fees per determination and per implementation based on patient complexity and membership level.


Gerard S. O’Connor MD FACS AOA
Executive Co-Chairman

Timed Health Co-Founder Angel Investor. Physician and Surgeon University of Maryland. Medical and Surgical Practice 3 Decades. Georgetown University BS. MD. George Washington University Surgery Board Certification. Lieutenant Colonel Retired Maryland Defense Force, 10th Medical Regiment, Medical Support for the National Guard. Current Maryland Health Care Commissioner.

Matt O'Connor
Executive Co-Chairman

Co-Founder Angel Investor. US Naval Officer. Prior Jet Aviator. Systems Engineer Annapolis US Naval Academy BS, Cornell MS. Executive at Allegheny Technologies.

James Applebach

Timed Health Co-Founder. Prior Executive Amazon OHL Bluestem. Prior CEO Cued Inc. Owner 1Click Logistics NV.

Suzanne Kay

Healthcare BSN Toledo University. MBA Pepperdine. Prior Integrated Delivery Networks. Early-Stage Healthcare Companies Investor.

Lance Brown
Software Manager

Prior Cued Inc.

Brian Sheridan
Software Manager

Prior Cued Inc.

Advisors and Investors

Non-Executive Board Members

John C. Matthews

Prior Healthcare Strategy Lead KPMG. Columbia University Faculty.

Jane Scaccetti

Drucker and Scaccetti Tax Warriors. BOD Public Companies.

Saul Reibstein

Finance, Prior Wall Street Fortune 500 Industry CFO, Partner CBIZ and BDO.

Consultancy Advisory Board

Rob Tibshirani PhD and
Jerry Friedman PhD

Stanford Department of Statistics. Machine Learning Pioneers.

Stefanos Poulis

Machine Learning Scientist.

Espir Kahatt

Engineer Electromechanical integration.

Andreas Vlachos PhD

University of Cambridge, UK. Senior Lecturer, Natural Language Processing.

Anne Merritt MD

Stanford Department of Medicine. Head of Health Product, Strategy & Operations, Google Search.

Jeff Skinner

Prior VP Hewlett Packard Enterprises and Block Chain.

Hadley Reynolds

Cognitive Computing Consortium, AI Pioneer.

Satish Srinivasan

DIRX Pharmacy.


VC LLC Venture Capital and Intellectual Property.

The Professionals

VC LLC. Matt O’Connor, Partner. US Naval Officer. Prior Jet Aviator. Systems Engineer Annapolis US Naval Academy BS, Cornell MS. Executive at Allegheny Technologies. The Professionals VC LLC is comprised of Investors and Professional Service Providers: Controllers UCI MBA. Technology. IP. MD. Board Certifications Stanford. University of Pennsylvania. University of California. Harvard. Mayo Clinic Rochester. University of the Sciences PharmD. Consultants Healthcare Businesses.

Steven Lee

Engineer Autonomous Vehicles, Tesla. GM.

Ernie Toth

Finance, prior CFO EHE Health, Aris Global, multiple healthcare successful exits.

Use of Proceeds

If the offering's maximum amount of $973,467 is raised:

UseValue% of Proceeds
Compensation for managers$60,0006.2%
Legal and Government Fees$100,00010.3%
Software Development$500,00051.4%
Marketing and Sales$200,00020.5%
Administration Fees, Hardware, Software$65,7676.8%
Intermediary fees$47,7004.9%


This is an offering of Class B Common Stock, under registration exemption 4(a)(6), in Timed Health Corporation. This offering must raise at least $10,000 by May 1, 2021 at 12:59am ET. If this offering doesn’t reach its target, then your money will be refunded. Timed Health Corporation may issue additional securities to raise up to $973,467, the offering’s maximum.

If the offering is successful at raising the maximum amount, then the company’s implied valuation after the offering (sometimes called its post-money valuation) will be:

$1 per share
$12,166,667implied valuation

Pitch Deck

arrows remove Created with Sketch.


These financial statements have been reviewed by an independent Certified Public Accountant.

SEC Filings

The Offering Statement is a formal description of the company and this transaction. It’s filed with the SEC to comply with the requirements of exemption 4(a)(6) of the Securities Act of 1933.

We’re also required to share links to each of the SEC filings related to this offering with investors.

Understand the Risks

Be sure to understand the risks of this type of investment. No regulatory body (not the SEC, not any state regulator) has passed upon the merits of or given its approval to the securities, the terms of the offering, or the accuracy or completeness of any offering materials or information posted herein. That’s typical for Regulation CF offerings like this one.

Neither Netcapital nor any of its directors, officers, employees, representatives, affiliates, or agents shall have any liability whatsoever arising from any error or incompleteness of fact or opinion in, or lack of care in the preparation or publication of, the materials and communication herein or the terms or valuation of any securities offering.

The information contained herein includes forward-looking statements. These statements relate to future events or to future financial performance, and involve known and unknown risks, uncertainties, and other factors, that may cause actual results to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond the company’s control and which could, and likely will, materially affect actual results, levels of activity, performance, or achievements. Any forward-looking statement reflects the current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. No obligation exists to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

More Info


Ask a Question

Proofread your comment before submitting: once it's posted, you can’t edit or delete it. Investors are advised to review our Discussion Board Policy before submitting a comment. For the fastest help with the web site, email help@netcapital.com instead of commenting.

Looking to raise capital?
We can help turn your friends, family and customers into investors.

Learn more

Interested in more investment opportunities?
Browse all offerings currently available.

See more